OPEN END TURBO OPTIONSSCHEIN SHORT - STRYKER CORP. Share Price

Certificat

DE000GQ9C5W9

Real-time BOERSE MUENCHEN 11:56:36 20/06/2024 pm IST
8.41 EUR +9.08% Intraday chart for OPEN END TURBO OPTIONSSCHEIN SHORT - STRYKER CORP.
Current month-10.35%
1 month-16.01%
Date Price Change
20/24/20 8.41 +9.08%
19/24/19 7.71 -2.77%
18/24/18 7.93 -3.29%
17/24/17 8.2 -2.26%
14/24/14 8.39 +0.24%

Real-time BOERSE MUENCHEN

Last update June 20, 2024 at 11:56 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying STRYKER CORPORATION
Issuer Goldman Sachs
WKN GQ9C5W
ISINDE000GQ9C5W9
Date issued 20/11/2023
Strike 432.3 $
Maturity Unlimited
Parity 10 : 1
Emission price 13.18
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 13.52
Lowest since issue 6.65
Spread 0.03
Spread %0.36%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
348.7 USD
Average target price
372.9 USD
Spread / Average Target
+6.96%
Consensus